Culturally adapted Spanish educational materials for Latino/a people with medullary thyroid cancer
Official title: Cultural Adaptation of an Educational Tool in Medullary Thyroid Cancer
Run by M.D. Anderson Cancer Center · NCT07142005 · Data updated 2026-11-12
This project will co-develop and test Spanish-language educational materials to help Latino/a adults with medullary thyroid cancer and their caregivers understand the disease and treatment options.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | August 15, 2025 |
| Main results expected | March 31, 2028 |
| Study ends | March 31, 2028 |
| Registry record updated | September 25, 2026 |
| Trial ID | NCT07142005 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (age ≥18) who identify as Hispanic or Latino/a, speak, read, and write Spanish, and who have medullary thyroid cancer or are nominated caregivers of someone with MTC are ideal candidates.
✕Probably not a fit
People who are non-Hispanic/non-Latino, under 18, unable to read/write/speak Spanish, or with significant cognitive/psychological impairment are not expected to benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will work with Latino/a patients and caregivers to adapt an existing MTC educational website into a culturally relevant Spanish-language decision aid using interviews and iterative feedback. The project includes phases of co-development, prototype testing with participants to measure understanding, and refinement based on user input. After production, acceptability will be measured among a broader group of Latino/a participants and caregivers using the Ottawa Acceptability Scale. The team will also collect basic clinical and demographic information from users and plan wider dissemination of the finalized tool.
Why it matters
Potential benefit: If successful, the tool could improve understanding, confidence, and decision-making for Spanish-speaking Latino/a patients with medullary thyroid cancer and their caregivers.
How similar studies have gone: Web-based decision aids and culturally adapted educational materials have improved understanding in other cancer populations, but a Latino/a-specific adaptation for medullary thyroid cancer is a novel application.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: * Provision of signed and dated informed consent form * Males and females; Age: ≥18 years old * Identified ethnicity as "Hispanic" or "Latino/Latina" * Ability to read, write, and speak Spanish * Those who are pregnant are eligible to participate * Have or will face this decision, including: a. Participant/survivor - who has medullary thyroid carcinoma, as determined by a clinician or documented in Multi-Institutional Medullary Thyroid Cancer Collaborative Registry; b. Caregiver/family member - of Participant/survivor who has medullary thyroid carcinoma, as nominated by the Participant/survivor Exclusion Criteria: * Those \< age 18 * Ethnic identity as non-Hispanic or non-Latino/a individual * Individuals with cognitive or psychological impairment (e.g., depression, anxiety, severe mental illness as documented in the registry
Where it's running
-
MD Anderson Cancer Center
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Elizabeth Grubbs, MD — eggrubbs@mdanderson.org
- Study coordinator: Elizabeth Grubbs, MD
- Email: eggrubbs@mdanderson.org
- Phone: 713-792-0665
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Digital Mental Health support for Asian Americans
We’re testing online digital tools to help Asian American adults cope with sociocultural stressors, by training clinicians and seeing if outcomes improve for clients.
-
Culturally Engaged Recovery for Native Mothers and Substance Use
This study tests a culturally tailored perinatal care model that blends pregnancy/postpartum care with substance use treatment for Indigenous mothers receiving prenatal care in Salt Lake City.
-
Preventing heart problems in overweight/obese young sarcoma survivors with tirzepatide
This feasibility study tests whether tirzepatide can be safely given to overweight or obese young adults (18–39) who have completed doxorubicin for soft tissue or bone sarcoma to see if it’s feasible to use in the first year after therapy.
-
Predicting lymphedema risk in inflammatory breast cancer patients using preoperative body impedance analysis
This study tests whether a preoperative bioimpedance test can help identify IBC patients who are at risk for developing lymphedema.
-
Precision genomic testing to guide first-line LBCL treatment readiness
Doctors will see if a tumor genomic test can help tailor first-line treatment for adults with LBCL by the start of the second cycle of standard therapy.
-
Using Apple Vision Pro in image-guided procedures
This study tests whether the Apple Vision Pro can be used during CT-guided biopsy procedures to help with imaging and guidance.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.